vs
Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and JOHN WILEY & SONS, INC. (WLY). Click either name above to swap in a different company.
JOHN WILEY & SONS, INC. is the larger business by last-quarter revenue ($421.8M vs $382.2M, roughly 1.1× LifeStance Health Group, Inc.). JOHN WILEY & SONS, INC. runs the higher net margin — 10.6% vs 3.1%, a 7.6% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs -1.1%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $-4.6M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs -4.3%).
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
John Wiley & Sons, Inc., commonly known as Wiley, is an American multinational publishing company which focuses on academic publishing and instructional materials. The company was founded in 1807 and produces books, journals, and encyclopedias, in print and electronically, as well as online products and services, training materials, and educational materials for undergraduate, graduate, and continuing education students.
LFST vs WLY — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $382.2M | $421.8M |
| Net Profit | $11.7M | $44.9M |
| Gross Margin | — | 75.2% |
| Operating Margin | 4.7% | 17.3% |
| Net Margin | 3.1% | 10.6% |
| Revenue YoY | 17.4% | -1.1% |
| Net Profit YoY | 264.1% | 11.0% |
| EPS (diluted) | — | $0.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $382.2M | $421.8M | ||
| Q3 25 | $363.8M | $396.8M | ||
| Q2 25 | $345.3M | $442.6M | ||
| Q1 25 | $333.0M | $404.6M | ||
| Q4 24 | $325.5M | $426.6M | ||
| Q3 24 | $312.7M | $403.8M | ||
| Q2 24 | $312.3M | $468.5M | ||
| Q1 24 | $300.4M | $460.7M |
| Q4 25 | $11.7M | $44.9M | ||
| Q3 25 | $1.1M | $11.7M | ||
| Q2 25 | $-3.8M | $68.1M | ||
| Q1 25 | $709.0K | $-23.0M | ||
| Q4 24 | $-7.1M | $40.5M | ||
| Q3 24 | $-6.0M | $-1.4M | ||
| Q2 24 | $-23.3M | $25.3M | ||
| Q1 24 | $-21.1M | $-113.9M |
| Q4 25 | — | 75.2% | ||
| Q3 25 | — | 72.5% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.2% | ||
| Q4 24 | — | 74.9% | ||
| Q3 24 | — | 73.0% | ||
| Q2 24 | — | 73.7% | ||
| Q1 24 | — | 68.8% |
| Q4 25 | 4.7% | 17.3% | ||
| Q3 25 | 2.0% | 7.8% | ||
| Q2 25 | -0.9% | 17.3% | ||
| Q1 25 | 0.5% | 12.8% | ||
| Q4 24 | 0.3% | 15.0% | ||
| Q3 24 | 0.0% | 7.2% | ||
| Q2 24 | -5.1% | 14.7% | ||
| Q1 24 | -5.6% | -10.1% |
| Q4 25 | 3.1% | 10.6% | ||
| Q3 25 | 0.3% | 2.9% | ||
| Q2 25 | -1.1% | 15.4% | ||
| Q1 25 | 0.2% | -5.7% | ||
| Q4 24 | -2.2% | 9.5% | ||
| Q3 24 | -1.9% | -0.4% | ||
| Q2 24 | -7.5% | 5.4% | ||
| Q1 24 | -7.0% | -24.7% |
| Q4 25 | — | $0.84 | ||
| Q3 25 | — | $0.22 | ||
| Q2 25 | — | $1.25 | ||
| Q1 25 | — | $-0.43 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $-2.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $248.6M | $67.4M |
| Total DebtLower is stronger | $282.8M | $871.7M |
| Stockholders' EquityBook value | $1.5B | $740.2M |
| Total Assets | $2.2B | $2.5B |
| Debt / EquityLower = less leverage | 0.19× | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $248.6M | $67.4M | ||
| Q3 25 | $203.9M | $81.8M | ||
| Q2 25 | $188.9M | $85.9M | ||
| Q1 25 | $134.3M | $104.5M | ||
| Q4 24 | $154.6M | $75.5M | ||
| Q3 24 | $102.6M | $82.5M | ||
| Q2 24 | $87.0M | $83.2M | ||
| Q1 24 | $49.5M | $93.1M |
| Q4 25 | $282.8M | $871.7M | ||
| Q3 25 | $284.6M | $828.3M | ||
| Q2 25 | $286.4M | $799.4M | ||
| Q1 25 | $288.2M | $887.2M | ||
| Q4 24 | $290.0M | $961.0M | ||
| Q3 24 | $287.3M | $918.6M | ||
| Q2 24 | $288.0M | $774.6M | ||
| Q1 24 | $288.8M | $906.8M |
| Q4 25 | $1.5B | $740.2M | ||
| Q3 25 | $1.5B | $733.1M | ||
| Q2 25 | $1.5B | $752.2M | ||
| Q1 25 | $1.5B | $685.2M | ||
| Q4 24 | $1.4B | $755.3M | ||
| Q3 24 | $1.4B | $713.7M | ||
| Q2 24 | $1.4B | $739.7M | ||
| Q1 24 | $1.4B | $748.3M |
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.1B | $2.5B | ||
| Q2 25 | $2.1B | $2.7B | ||
| Q1 25 | $2.1B | $2.6B | ||
| Q4 24 | $2.1B | $2.6B | ||
| Q3 24 | $2.1B | $2.7B | ||
| Q2 24 | $2.1B | $2.7B | ||
| Q1 24 | $2.1B | $2.7B |
| Q4 25 | 0.19× | 1.18× | ||
| Q3 25 | 0.19× | 1.13× | ||
| Q2 25 | 0.19× | 1.06× | ||
| Q1 25 | 0.20× | 1.29× | ||
| Q4 24 | 0.20× | 1.27× | ||
| Q3 24 | 0.20× | 1.29× | ||
| Q2 24 | 0.20× | 1.05× | ||
| Q1 24 | 0.20× | 1.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $57.6M | $8.5M |
| Free Cash FlowOCF − Capex | $46.6M | $-4.6M |
| FCF MarginFCF / Revenue | 12.2% | -1.1% |
| Capex IntensityCapex / Revenue | 2.9% | 3.1% |
| Cash ConversionOCF / Net Profit | 4.93× | 0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $110.0M | $162.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | $8.5M | ||
| Q3 25 | $27.3M | $-85.0M | ||
| Q2 25 | $64.4M | $150.3M | ||
| Q1 25 | $-3.1M | $146.2M | ||
| Q4 24 | $62.3M | $-5.3M | ||
| Q3 24 | $22.7M | $-88.7M | ||
| Q2 24 | $44.1M | $183.3M | ||
| Q1 24 | $-21.8M | $107.8M |
| Q4 25 | $46.6M | $-4.6M | ||
| Q3 25 | $17.0M | $-97.0M | ||
| Q2 25 | $56.6M | $131.2M | ||
| Q1 25 | $-10.3M | $132.9M | ||
| Q4 24 | $56.0M | $-19.8M | ||
| Q3 24 | $17.7M | $-103.2M | ||
| Q2 24 | $39.0M | $164.5M | ||
| Q1 24 | $-26.9M | $90.9M |
| Q4 25 | 12.2% | -1.1% | ||
| Q3 25 | 4.7% | -24.4% | ||
| Q2 25 | 16.4% | 29.6% | ||
| Q1 25 | -3.1% | 32.9% | ||
| Q4 24 | 17.2% | -4.6% | ||
| Q3 24 | 5.7% | -25.6% | ||
| Q2 24 | 12.5% | 35.1% | ||
| Q1 24 | -9.0% | 19.7% |
| Q4 25 | 2.9% | 3.1% | ||
| Q3 25 | 2.8% | 3.0% | ||
| Q2 25 | 2.2% | 4.3% | ||
| Q1 25 | 2.2% | 3.3% | ||
| Q4 24 | 1.9% | 3.4% | ||
| Q3 24 | 1.6% | 3.6% | ||
| Q2 24 | 1.6% | 4.0% | ||
| Q1 24 | 1.7% | 3.7% |
| Q4 25 | 4.93× | 0.19× | ||
| Q3 25 | 25.34× | -7.27× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | -4.36× | — | ||
| Q4 24 | — | -0.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 7.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFST
Segment breakdown not available.
WLY
| Research Publishing | $241.4M | 57% |
| Academic Products | $87.0M | 21% |
| Professional Products | $56.2M | 13% |
| Research Solutions | $37.1M | 9% |
